Description

Truxal (chlorprothixene) Coated Tablets 50 mg. №50 Vial

Ingredients

Active ingredient: Chlorprothixene 50 mg per tablet.

Dosage

Dosage: The usual adult dose is 30-75 mg daily in divided doses. Dosage should be individualized based on the condition being treated and the patient’s response.

Indications

Indications: Truxal tablets are indicated for the treatment of various psychiatric disorders, including schizophrenia, manic episodes, and severe anxiety.

Contraindications

Contraindications: Do not use Truxal tablets in patients with hypersensitivity to chlorprothixene or other phenothiazines. It is contraindicated in comatose or severely depressed patients.

Directions

Directions: Take Truxal tablets orally with or without food as directed by your healthcare provider. Do not crush or chew the tablets.

Scientific Evidence

Truxal (chlorprothixene) has been extensively studied for its efficacy in managing various psychiatric conditions. Research published in the Journal of Clinical Psychopharmacology demonstrated the effectiveness of chlorprothixene in reducing the symptoms of schizophrenia compared to placebo.

Additional Information

It is important to follow the prescribed dosage and not exceed the recommended amount to avoid potential side effects. Consult your healthcare provider for more information on the use of Truxal tablets.

Pharmacological Effects: Chlorprothixene exerts its antipsychotic effects by blocking dopamine receptors in the brain, leading to a reduction in psychotic symptoms. It also has sedative and anxiolytic properties, making it useful in managing anxiety disorders.

Clinical Trials: A randomized controlled trial published in the Journal of Clinical Psychiatry compared the effectiveness of chlorprothixene with other antipsychotic medications in the treatment of acute schizophrenia. The study found that chlorprothixene was as effective as other antipsychotics with a favorable side effect profile.